NanoMedicine is a Research Department in The University of Texas Department of Biomedical Engineering at The University of Texas Health Science Center at Houston , directed by Professor Mauro Ferrari. The University of Texas Department of Biomedical Engineering is an Inter-Institutional Department formed by three University of Texas System components, The University of Texas at Austin, University of Texas M. D. Anderson Cancer Center and The University of Texas Health Science Center at Houston.

The Department of NanoMedicine focuses on inter-disciplinary research to combine nano-engineering, mathematical modeling and biomedical sciences to develop nanotechnology enabled therapeutic and diagnostic platforms for combating diseases including cancer, cardiovascular diseases and infectious diseases.

Our ongoing research projects include:

• Early Detection of Disease from Blood Proteomic Signatures
• Injectable NanoVectors for Directed (Targeted/personalized) Therapeutics
• Intelligent Implants for Controlled Time Release of Therapy
• BioNanoScaffolds for Post-Traumatic OsteoRegeneration

More on research...

Alliance for NanoHealth Sponsored Conference

Selected Publications

V Gewin (2009).
Big opportunities in a small world
Nature 460(23): 540-541.

M Ferrari (2009).
Straight talk with... Mauro Ferrari
Nature Medicine 15(7): 716-717.

M Ferrari, MA Philibert, WR Sanhai (2009).
Nanomedicine and Society
Clinical Pharmacology and Therapeutics 85(5): 466-467.

J Evans (2009).
Five big ideas for nanotechnology
Nature Medicine 15(4): 348.

M Ferrari (2008).
Nanogeometry: Beyond Drug Delivery
Nature Nanotechnology 3(3):131-132.

W Sanhai, J Sakamoto, R Canady and M Ferrari (2008).
Seven Challenges for Nanomedicine
Nature Nanotechnology 3(5):242-244.

E Tasciotti, X Liu, K Plant, A Leonard, B Price, M Cheng, P Decuzzi, J Tour, F Robertson and M Ferrari (2008).
Mesoporous Silicon Particles as a Multistage Delivery System for Imaging and Therapeutic Applications
Nature Nanotechnology 3(3):151-157.

M Ferrari (2006).
nan'o tech nol'o gy n.
Nature Nanotechnology 1:8-10.

M Ferrari (2005).
Cancer nanotechnology: opportunities and challenges
Nature Reviews Cancer 5:161-171.

L Liotta, M Ferrari and E Petricoin (2003).
Clinical proteomics: Written in blood
Nature 425:905.